EMDSerono Profile Banner
EMD Serono Profile
EMD Serono

@EMDSerono

Followers
9K
Following
1K
Statuses
5K

EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany in the US & Canada. Imagining the future of healthcare. CGs: https://t.co/x2hRpEoQ4x

Boston, MA
Joined May 2012
Don't wanna be here? Send us removal request.
@EMDSerono
EMD Serono
53 minutes
We’re sharing updates from our oncology portfolio at ASCO #GU25 including real-world data. Hear from Sebastien Michaud and find more meeting information here: #HCPsOnly
0
0
0
@EMDSerono
EMD Serono
6 days
@DanniReprints We appreciate your comment, but please note that our community guidelines advise that medications cannot be mentioned on our corporate channels. We have removed the tag of our account alignment with this guidance.
0
0
0
@EMDSerono
EMD Serono
2 months
Our scientists are investigating the power of protein degradation in #cancer research. Watch our video to see how this promising approach may help more cancer patients become cancer survivors. #ScienceOfCancer
0
1
2
@EMDSerono
EMD Serono
3 months
@FoundationATCG We are pleased to see that the FDA approved a biomarker test for identifying MET Exon 14 Skipping Alterations in NSCLC. Biomarker testing can play a crucial role in treatment decision-making and can empower physicians to select a treatment option.
0
0
0
@EMDSerono
EMD Serono
3 months
An investigative treatment being developed by our partner Abbisko Therapeutics shows potential to meet unmet needs for patients with Tenosynovial Giant Cell Tumor (TGCT). 👉 Read more here: #AsOneForPatients #PhaseIII #TGCT #Oncology
0
1
1
@EMDSerono
EMD Serono
4 months
Proud to support our veterans!
@bwforg
Bob Woodruff Foundation
4 months
Grateful for @EMDSerono support in sponsoring Stand Up for Heroes 2024! Your commitment helps us continue making a difference for veterans and their families 🇺🇸🫡 #StandUpForHeroes #Veterans @craignewmark @BobWoodruff
Tweet media one
1
1
2
@EMDSerono
EMD Serono
4 months
Those looking to grow their families through third party reproduction are faced with a unique set of challenges. Join us for our final expert session in booth #4022, as Brian Levine of CCRM NY discusses digital advances in third party reproduction. #ASRM2024 #IVF #infertility
Tweet media one
0
1
1
@EMDSerono
EMD Serono
4 months
#DEI is fundamental to advancing fertility care. Join us at 3 PM in Booth 4022 to learn more about project achievements of last years' recipients of both the EMD Serono and @ASRM_org Diversity Fellowship Awards. #ASRM2024 #Infertility
Tweet media one
0
1
1
@EMDSerono
EMD Serono
4 months
Are you an #OBGYN or #REI seeing more interest in egg-freezing than ever? Stop by booth #4022 @ASRM_org at 10:05AM to hear from Monica Pasternak, MD of Spring Fertility to share her latest experiences and tips on handling patients seeking egg freezing. #ASRM2024
Tweet media one
0
0
1
@EMDSerono
EMD Serono
4 months
If you’re joining @ASRM_org annual meeting, stop by booth #4022 to hear from experts discussing the latest exciting topics in fertility, including planned OC (egg freezing) and DE&I research in the fertility space. #ASRM2024 #Infertility #IVF
0
1
1
@EMDSerono
EMD Serono
4 months
The prevalence of egg freezing is increasing w/ different patient needs and expectations. If you’ll be at the @ASRM_org meeting, join us in the Mile High Ballroom on 10/21 at 12:20 PM to explore the unmet needs of this growing patient demographic. #ASRM2024 #IVF
Tweet media one
0
1
2
@EMDSerono
EMD Serono
4 months
Who’s ready for #ASRM2024? ✋ Stop by Booth #4022 to see how we’re reimagining the future of fertility care, together. See you in Denver, @ASRM_org! #Fertility #IVF
0
0
1
@EMDSerono
EMD Serono
4 months
Our tumor immunology research scientists are exploring how T-cell modulation can contribute to the next generation of immuno-oncology therapies and further advance cancer care. Learn more about T-cell modulation. #ScienceOfCancer
0
4
11
@EMDSerono
EMD Serono
4 months
@christymaginn We appreciate your comment, but please note our community guidelines advise that medications cannot be mentioned on our corporate channels. We have removed the tag of our profile in alignment with this guidance:
1
0
0
@EMDSerono
EMD Serono
4 months
We had an incredible time at @ECTRIMS, last week sharing our latest #MultipleSclerosis research and data, plus eco-friendly initiatives. It was a pleasure meeting fellow experts to discuss the #MS Treatment Landscape. #HCPsOnly #MultipleSclerosis #ECTRIMS2024
Tweet media one
0
0
0
@EMDSerono
EMD Serono
5 months
📅 We’re thrilled to be at #ECTRIMS2024 in Copenhagen from September 18-20, celebrating its 40th year with 40 abstracts of our own about our ground-breaking research in #MultipleSclerosis. 👋 See you soon! #HCPsOnly #Neurology
0
0
0
@EMDSerono
EMD Serono
5 months
Intrigued by our ADC data at #ASCO24? We’re presenting longer follow-up data and new biomarker analysis from our Phase I study at #ESMO24 on September 16 (presentation 573P): #ScienceOfCancer #HCPsOnly
1
1
7
@EMDSerono
EMD Serono
5 months
We’re exploring the potential of #DDR inhibitor combinations to synergistically enhance synthetic lethality and increase #cancer cell death. Join us at #ESMO24 on September 15 in Hall 6 for insights into our latest research (presentation 193P): #HCPsOnly
2
5
13
@EMDSerono
EMD Serono
5 months
📣 NEWS: At #ECTRIMS, new data will be presented in #MultipleSclerosis, including central inflammation data and real-world evidence drawn from multiple four-year sub-studies. Find out more:
Tweet media one
0
0
0
@EMDSerono
EMD Serono
5 months
Hear from our oncology leaders on why they’re excited for #ESMO24. From sponsoring symposia to presenting oncology data, we’re eager to collaborate with the global #cancer community to help improve the future for patients.
0
2
5